Hematology and Oncology

EmailEmail    |   Bookmark Page Bookmark  |   RSS Feeds RSS  |   Print Page Print  

J. Douglas Rizzo, MD, MSJ. Douglas Rizzo, MD, MS

Best Doctors 2014 - J. Douglas Rizzo, MD, MS

Associate Scientific Professor, CIBMTR

Professor of Medicine




Dr. J. Douglas Rizzo has ten years of experience with the Center for International Blood and Marrow Transplant Research (CIBMTR) at the Medical College of Wisconsin, an internationally recognized research organization. In his role as CIBMTR Associate Scientific Director and CIBMTR program leader for observational research, he has had primary responsibility for data operations and management staff oversight. He is responsible for implementation of the Stem Cell Therapeutics Outcomes Database at the CIBMTR, part of the national C.W. Bill Young Cell Transplantation Program. His research interests include late effects and quality of life after Hematopoietic Cell Transplantation (HCT), access to HCT across gender and ethnic/racial groups and other health policy issues. Dr. Rizzo is an attending physician in the MCW adult HCT unit, with clinical interests in hematologic malignancies and late effects of HCT. He completed a fellowship in hematology/oncology and a Robert Wood Johnson fellowship in epidemiology and cost-effectiveness research at Johns Hopkins University and holds an MS degree in epidemiology from MCW. He has taken a leadership role in several American Society of Hematology initiatives and participated in several committees. He is also an active member of the American Society for Blood and Marrow Transplant Quality Outcomes, Standardization of Outcomes, and Evidence Based Review Steering Committees. 

Selected Publications

Rizzo JD, Curtis RE, Socie G, Sobocinski KA, Gilbert E, Landgren O, Travis LB, Travis WD, Flowers MED, Friedman D, Horowitz MM, Wingard JR, Deeg HJ. Solid cancers after allogeneic hematopoietic cell transplantation. Blood 113:1175-1183, 2009.

Landgren O, Gilbert ES, Rizzo JD, Socie G, Banks PM, sobocinski KA, Horowitz MM, Jaffe ES, Kingma DW, Travis LB, Flowers Me, Martin PJ, Deeg HJ, Curtis RE. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood 113:4992-5001, 2009.

Majhail NS, Bajorunaite R, Lazarus HM, Wang Z, Klein JP, Zhang M-J, Rizzo JD. Long-term survival and late relapse in 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and non-Hodgkin-lymphoma. Br J Haematol 147:129-139, 2009.

Baker KS, Davies SM, Majhail N S, Hassebroek A, Klein JP, Ballen KK, Bigelow CL, Frangoul HA, Hardy CL, Lee SJ, Rizzo JD. Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant 15:1543-1554, 2009.

Goldman JM, Majhail NS, Klein JP, Wang Z, Sobocinski KA, Arora M, Horowitz MM, Rizzo JD. Relapse and late mortality in 5-year survivors of myeloablative allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in first chronic myeloid leukemia in first chronic phase. J Clin Oncol 28:1888-1895, 2010.

Joshua TV, Rizzo JD, Zhang M-J, Hari PN, Kurian S, Pasquini M, Majhail NS, Lee SL, Horowitz MM. Access to hematopoietic stem cell transplantation effect of race and gender. In press, to be published May 24th.


Best Doctors® is a registered trademark of Best Doctors, Inc. in the United States and other countries.
© 2014 Medical College of Wisconsin
Page Updated 11/04/2014